It's not only the pain in my leg, it's the pain in my heart and the pain in my mind.
David, who was 21 years old and dying of metastatic osteosarcoma, was withdrawn and felt hopelessness and despair. He was profoundly depressed and over several conversations was able to share some of the enormous pain of being depressed. He described it as far worse than any physical pain he had experienced and as a "place of utter emptiness...a place where nobody else can ever enter."
Depression is known to be a symptom for approximately 25 percent of palliative care patients, 1 but is frequently not diagnosed. Although depression can occur in any patient, young age is an important factor in the development of psychiatric morbidity. 2 The assessment of depression in terminally ill patients is difficult. Studies have shown that patients underestimate their own distress, as they may not want to bother the doctor or appear to be a bad or weak patient.
Research also indicates that asking an informant, e.g., close friends or relatives, is also unhelpful since their estimation of psychological distress is a closer measure of their own distress than of the patient. 3 Our patients are invariably sad as their life draws to a close, and how do we distinguish between what could be called "appropriate sadness" and a depressive illness? There are no biological markers, physical signs, or effective diagnostic tests to help in the diagnosis.
While it is acknowledged that some patients with depression may require expert psychiatric assessment, many patients can be adequately assessed by a doctor or nurse who has developed the necessary skills to do so. Ideally there should be an integrated referral system where patients can either be discussed or referred to a psychiatrist and a plan of management initiated. 4 There are no universally accepted criteria for diagnosing depression in the terminally ill. In patients with advanced cancer, many of the symptoms of depression, e.g., changes in appetite, energy levels and sleep patterns, are almost universal and there is still considerable controversy as to the importance of these physical symptoms in diagnosing depression in the terminally ill.
How can the doctor or nurse working in a palliative care unit or hospice establish that a patient is depressed and requires treatment or further assessment? One method that is gaining increasing popularity is to use a rating scale. Depression is comprised of different constructs, and scales have been devised measuring the different elements, e.g., cognition, behavior, somatic symptoms and others, and different scales measure different facets of a depressive illness. 5 Such criteria are not diagnostic tools and can serve only to indicate whether a patient has particular psychiatric symptoms suggesting a diagnosis of depression. The decision should be made then on whether to treat for depression or refer the patient for further assessment. Most rating scales consist of a number of symptoms or feelings to which patients indicate their own response and the person administering the scale calculates the scores.
Several instruments have been developed and researched with a particular score or cutoff threshold assigned in order to predict a "case" of depression. However a cutoff threshold for patients with early cancer or those receiving treatment may not be valid in those patients with advanced metastatic disease receiving palliative care. 6, 7 Scales devised for other populations may have a role in palliative care. Recent work has suggested that a scale developed for use in the post-natal period may be useful for screening in palliative care, due to its noninclusion of somatic symptoms but inclusion of symptoms such as subjective sadness, feelings of helplessness, and thoughts of self harm-symptoms which may be particularly relevant to the palliative care population. 8, 9 There are other methods available to screen for depression in addition to itemized scales. Asking patients directly if they are depressed has been found to be a useful indicator as to whether patients may be depressed, but researchers emphasize that patients only have their own experience by which to judge their responses. 10 Responses to this question would also depend on the patient's level of understanding and factors such as cultural acceptance of depression; the patient's native language could also preclude the use of such a question. Visual analogue scales have been used in patients with cancer, 11 but again the subjective experience of the patient may lead to either under or over scoring. Both these methods, however, would be quick and easy to administer and need further evaluation and validation.
Depression is a common symptom in patients with terminal cancer. The prevalence of psychiatric morbidity within terminally ill patients should be highlighted to those responsible for their care including home care nursing teams, community physicians, oncology specialists and palliative care physicians. Patients who are depressed may also have physical symptoms which are difficult to palliate and which may improve as their depression is appropriately treated. There are many antidepressants available with acceptable side effect profiles and patients identified as depressed even within the last four to six weeks of life may still benefit from treatment.
The emphasis on case definition and case identification must not obscure what has been described, i.e., instead of asking "Has he got it?" or "How much of it has she got?" the question is "What is it?" i.e., What exactly are patients experiencing and what are the most appropriate means of helping or treating these patients? 12 The proliferation of new rating scales and their ad-hoc use needs careful evaluation. 13 The increased use of rating scales and other methods of assessment should be accompanied by a validation of treatment to establish which patients should be screened in order to benefit from treatment. There is much research to be done and much that we do not know about the etiology, meaning and treatment of depression in our patients.
